• editor.aipublications@gmail.com
  • Track Your Paper
  • Contact Us
  • ISSN: 2456-8015

International Journal Of Medical, Pharmacy And Drug Research(IJMPD)

Clinical Manifestations of Plasmodium bergheiANKA Infection in Juvenile Mice: A Short Case Report

J.B. Ajayi , A. O. Agbeyangi , A. Daniel , I. Omobolaji , H.O. Mogaji

International Journal of Medical, Pharmacy and Drug Research(IJMPD), Vol-1,Issue-1, May - June 2017, Pages 8-11 ,

Download | Downloads : 16 | Total View : 1024


Malaria is an important health and development challenge in Africa, Animalmodels most particularly mice, have long been employedto study malaria pathogenesis. Clinical manifestations due to Plasmodium bergheiANKA infection in juvenile mice as a model for understanding the complications ofcongenital malaria in neonates.Forty-five juvenile mice (5-7 days old) were acquired from University College Hospital, Ibadan and injected with 2 x 107 (0.2ml) Plasmodium berghei ANKA parasitized red blood cells (PRBCs). Mice were transported to the study site, kept in well ventilated cages and fed daily with a balanced ration. Every day after post-P. berghei infection, mice were monitored for mortality. Clinical manifestations ofexperimental cerebral malaria (ECM) was assessed and confirmed if at leastruffled fur, hunching, wobbly gait, limb paralysis, convulsions, or coma was observed. Each sign was given a score of 1. Animals with scores ≥4 were considered to have severe ECM.20 (44%) micewerelost due to natural cause (i.e. stress) at day 2 of the experiment. Between day 4 and 9, 25 (56%) of the studymice presented clinical signs of ECM which includes; ruffled fur 25(100%), hunching 21 (84%), wobbly gait 17 (68%), limb paralysis 20 (80%), convulsions 25 (100%) and subsequently died. Survival rate and severity of ECM in the mice differs, 22 (88.0%) had severe ECM and 3(12.0%) had mild ECM.This study has shown that parasite establishment and malaria complications can manifest as early as 4 days’postP. berghei infection in 5-7 days old mice.

Malaria, Neonates, Juvenile, Mice, ECM.

[1] WHO, (2015). Fact Sheet. World Malaria Report 2015. Geneva, Switzerland, World Health Organization.
[2] WHO, (2015). Fact Sheet. Malaria. Media centre. Geneva, Switzerland, World Health Organization
[3] Druilhe P, Hagan P, Rook GAW. (2002). The importance of models of infection in the studyof disease resistance. Trends Microbiol.,10(10): 38-46.
[4] Basi, R., FazalulRahiman, S.S., Hasballah, K., Chong, WC., Talib, H., Yam, MF., Jabbarzare, M., Tie, TH., Othman, F. Moklas, M.M., Abdullah, W.O. and Ahmad, Z (2012). Plasmodium bergheiANKA Infection in ICR Mice as a Model of Cerebral Malaria. Iranian J Parasitol. 7(4) 62-74
[5] Hunt NH, Grau GE. (2003). Cytokines: accelerators and brakes in the pathogenesis of cerebral malaria. Trends Immunol., 24(9): 491-499.
[6] Combes V, de Souza JB, Renia L, Hunt NH, Grau GE. (2005). Cerebral malaria: which parasite?Which model? Drug Disc Today; 2(2):141-147.
[7] Clark, I.A andRockett, K.A (1994). The cytokine theory of human cerebral malaria. Parasitol Today. 10(10): 410-412.
[8] Artavanis-Tsakonas, K. and Riley, E.M (202). Innate immune response to malaria: rapid induction of IFNγ from human NK cells by live Plasmodium falciparum-infected erythrocytes. J Immunol., 169(6): 2956-2963
[9] Wu, J.J., Chen, G., Liu, J., Wang, T., Zheng, W and Co, Y.M (2010). Natural regulatory T cells mediate the development of cerebral malaria by modifying the pro-inflammatory response. Parasitol Int.59:232–241.